We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
695
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZKIN icon
3926
ZK International Group
ZKIN
$77.4M
$73K ﹤0.01%
10,191
-12,583
-55% -$101K
AMPE
3927
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$73K ﹤0.01%
1,453
-6,106
-81% -$454K
INUV icon
3928
Inuvo
INUV
$15.1M
$71K ﹤0.01%
14,410
+9,170
+175% +$40.8K
OTRK
3929
DELISTED
Ontrak
OTRK
$71K ﹤0.01%
746
+360
+93% +$50.4K
AKAN icon
3930
Akanda
AKAN
$2.87M
$70K ﹤0.01%
+2
New +$497K
MOGU
3931
MOGU Inc
MOGU
$16.5M
$70K ﹤0.01%
31,157
+3,250
+12% +$7.67K
BPTH
3932
DELISTED
Bio-Path Holdings Inc
BPTH
$70K ﹤0.01%
+900
New +$60.8K
FHS
3933
DELISTED
First High-School Education Group Co., Ltd. American Depositary Shares (each representing three (3) Class A Ordinary Shares)
FHS
$70K ﹤0.01%
87,200
+27,500
+46% +$29K
AMBO
3934
Ambow Education Holding
AMBO
$5.66M
$69K ﹤0.01%
18,764
+2,352
+14% +$14.6K
HOWL icon
3935
Werewolf Therapeutics
HOWL
$17.2M
$69K ﹤0.01%
+16,800
New +$76.7K
IMNM icon
3936
Immunome
IMNM
$2.58B
$69K ﹤0.01%
21,500
+7,500
+54% +$27.3K
NVX
3937
NOVONIX
NVX
$99M
$69K ﹤0.01%
+10,499
New +$130K
TIRX
3938
DELISTED
Tian Ruixiang Holdings
TIRX
$69K ﹤0.01%
763
+207
+37% +$21.4K
CPHI icon
3939
China Pharma Holdings
CPHI
$45M
$68K ﹤0.01%
638
-71
-10% -$9.5K
BGMS
3940
Bio Green Med Solution Inc
BGMS
$4.91M
$68K ﹤0.01%
+18
New +$109K
TOPS icon
3941
TOP Ships
TOPS
$3.49M
$68K ﹤0.01%
+752
New +$123K
CLRB icon
3942
Cellectar Biosciences
CLRB
$20.5M
$67K ﹤0.01%
555
+132
+31% +$18.9K
CLWT icon
3943
Euro Tech Holdings
CLWT
$11M
$67K ﹤0.01%
54,100
-41,990
-44% -$61.2K
AEHL icon
3944
Antelope Enterprise Holdings
AEHL
$8.63M
$66K ﹤0.01%
26
-23
-47% -$55.8K
RKTO
3945
Rocket One Inc
RKTO
$17.9M
$66K ﹤0.01%
6,290
+2,754
+78% +$35.1K
PPSI
3946
Pioneer Power Solutions
PPSI
$32.3M
$66K ﹤0.01%
+22,900
New +$93.4K
AUUD
3947
Auddia
AUUD
$5.47M
$65K ﹤0.01%
+23
New +$110K
CING icon
3948
Cingulate
CING
$64.5M
$65K ﹤0.01%
186
-27
-13% -$9.31K
ITRM
3949
DELISTED
Iterum Therapeutics
ITRM
$65K ﹤0.01%
21,553
+14,346
+199% +$53.7K
LPCN icon
3950
Lipocine
LPCN
$17.5M
$65K ﹤0.01%
4,765
+3,936
+475% +$61.3K

Similar funds

Renaissance Technologies's Q2 2022 Portfolio in Review

As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
  • Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
  • Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.